跳至主要内容
临床试验/SLCTR/2022/003
SLCTR/2022/003招募中3 期

Dextran in Early Leakage Phase of Dengue Prevents Shock

Rajarata University of Sri Lanka & University of Peradeniya0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. All male and female patients
  • 2. Aged 18 and above
  • 3. Diagnosed with dengue fever

排除标准

  • 1.Patients who have evidence of advanced plasma leakage or established on admission
  • 2.Known hypersensitivity to dextran
  • 3.Pregnant mothers & children
  • 4.Patients with acute kidney injury
  • 5.Advanced CKD (Stage V)
  • 6.Severe heart failure (NYHA class III & IV)
  • 7.Severe liver disease (Child’s C)
  • 8.Diabetics with autonomic dysfunction
  • 9.Patients on beta blockers, calcium channel blockers and sinus node blockers

研究者

发起方
Rajarata University of Sri Lanka & University of Peradeniya

相似试验